-
Becton Dickinson Considers Spinning Off Life Sciences Division
•
US-based Becton, Dickinson and Co. (BD) is reportedly considering spinning off its life sciences division, which is estimated to be valued at approximately $30 billion, according to sources cited by Reuters. The move is seen as a strategic effort to potentially boost the company’s stock price. Exploring Feasibility and TimingBD…
-
Becton, Dickinson and Co. Launches RMB1.332 Billion Factory in Jiangsu for Pre-Filled Syringes
•
US-based Becton, Dickinson and Co., (BD) has officially put into operation its new factory in Yixing, Jiangsu province, with an investment worth RMB1.332 billion (USD182.5 million). This plant marks BD’s third world-class local production base in China and is now the central facility for local manufacturing of BD pre-filled flush…
-
Hantech Medical Device Co., Ltd Acquires BD’s Villamarzana Factory to Expand Manufacturing
•
China-based Hantech Medical Device Co., Ltd, a Contract Development Manufacturing Organization (CDMO) specializing in medical consumables, has announced the buyout of Becton, Dickinson and Company’s (BD) factory located in Villamarzana, Italy. This acquisition includes all assets such as land, factory buildings, and equipment. Concurrently, the US major has reached an…
-
Novogene and Becton, Dickinson Partner to Advance Single Cell Sequencing Technologies
•
Novogene (SHA: 688315), a genomic services and solutions provider based in Beijing and operating globally, has entered into a strategic partnership with US medical technology giant Becton, Dickinson and Co. (BD). The collaboration focuses on the single cell instrument HT Xpress and the establishment of a joint laboratory dedicated to…
